FibroGen Inc (FGEN)
0.3872
+0.04
(+10.63%)
USD |
NASDAQ |
Nov 21, 16:00
0.3755
-0.01
(-3.02%)
After-Hours: 05:46
FibroGen Market Cap: 39.02M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 39.02M |
| November 20, 2024 | 35.27M |
| November 19, 2024 | 35.27M |
| November 18, 2024 | 34.00M |
| November 15, 2024 | 33.73M |
| November 14, 2024 | 37.27M |
| November 13, 2024 | 33.48M |
| November 12, 2024 | 38.96M |
| November 11, 2024 | 34.12M |
| November 08, 2024 | 32.55M |
| November 07, 2024 | 31.52M |
| November 06, 2024 | 31.28M |
| November 05, 2024 | 30.94M |
| November 04, 2024 | 32.79M |
| November 01, 2024 | 32.14M |
| October 31, 2024 | 30.37M |
| October 30, 2024 | 32.02M |
| October 29, 2024 | 30.86M |
| October 28, 2024 | 30.11M |
| October 25, 2024 | 31.04M |
| October 24, 2024 | 32.25M |
| October 23, 2024 | 32.25M |
| October 22, 2024 | 35.30M |
| October 21, 2024 | 37.74M |
| October 18, 2024 | 39.45M |
| Date | Value |
|---|---|
| October 17, 2024 | 39.80M |
| October 16, 2024 | 37.86M |
| October 15, 2024 | 35.71M |
| October 14, 2024 | 34.57M |
| October 11, 2024 | 36.01M |
| October 10, 2024 | 33.96M |
| October 09, 2024 | 33.02M |
| October 08, 2024 | 33.09M |
| October 07, 2024 | 34.52M |
| October 04, 2024 | 36.95M |
| October 03, 2024 | 40.20M |
| October 02, 2024 | 40.30M |
| October 01, 2024 | 39.50M |
| September 30, 2024 | 40.25M |
| September 27, 2024 | 40.80M |
| September 26, 2024 | 39.32M |
| September 25, 2024 | 37.45M |
| September 24, 2024 | 38.52M |
| September 23, 2024 | 37.36M |
| September 20, 2024 | 41.02M |
| September 19, 2024 | 41.77M |
| September 18, 2024 | 42.17M |
| September 17, 2024 | 44.99M |
| September 16, 2024 | 45.40M |
| September 13, 2024 | 47.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
30.11M
Minimum
Oct 28 2024
5.102B
Maximum
Feb 12 2021
1.684B
Average
1.329B
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.09B |
| Arbutus Biopharma Corp | 655.64M |
| GlycoMimetics Inc | 20.63M |
| Cidara Therapeutics Inc | 122.96M |
| Cue Biopharma Inc | 65.25M |
Market Cap Related Metrics
| PS Ratio | 0.2139 |
| Price | 0.3872 |
| Earnings Yield | -317.7% |